Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-05

Clinical Trial Update: The Efficacy of Xuebijing Injection on Sepsis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial updating on the efficacy of Xuebijing Injection for sepsis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Xuebijing Injection

Snippet

Sponsor: Southeast University, China | Conditions: Sepsis | Phase 4 | Status: COMPLETED